Press "Enter" to skip to content

Single dose of Pfizer-BioNTech and Oxford-AstraZeneca is more than 80 percent effective in preventing hospitalizations – Health News

The UK Public Health Agency published the first findings on the effect of Pfizer-BioNTech and Oxford-AstraZeneca vaccines in reducing Covid-19 infections.

Accordingly, 4 weeks after the vaccine, it was determined that a single dose of the Pfizer-BioNTech vaccine was 57-61 percent effective in protection against Covid-19, and the Oxford-AstraZeneca vaccine was 60-73 percent effective.

It was determined that a single dose of both vaccines was more than 80 percent effective in preventing hospitalizations in those aged 80 and over approximately 3-4 weeks after vaccination. Evidence was also found showing that the Pfizer vaccine reduced deaths from Covid-19 by 83 percent.

Health Minister Matt Hancock, in a statement at the daily press conference, commented that the findings were “very strong” and noted that vaccines seem to help both reduce the pressure on hospitals and save lives.

With the effect of a faster and more lethal type of Covid-19, incidents and deaths increased in England.

The most daily cases in the country were recorded on December 29 with 81 thousand 547, and the most casualties were recorded between 1820 and 20 January.

However, with the effect of both the quarantine and the vaccine that started on January 5, daily cases have decreased to less than 10 thousand and casualties to less than 500 in recent weeks.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *